Earnings Feed
Start Free
Home/Filings/4/0001235802-11-000126
4//SEC Filing

Ryan Michael E 4

Accession 0001235802-11-000126

CIK 0001114200other
View on SEC.govCompany Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 3:26 PM ET

Size

33.7 KB

Accession

0001235802-11-000126

Insider Transaction Report

Form 4
Period: 2011-06-17
AMERICAN MEDICAL SYSTEMS HOLDINGS INCAMMD
Ryan Michael E
VP and General Manager - APLAC
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−8,250→ 24,750 total
    Exercise: $18.46Exp: 2017-02-11→ Common Stock (8,250 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−3,750→ 0 total
    Exercise: $14.36Exp: 2015-03-05→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Common Stock

    2011-06-17−15,276.306→ 4,633 total
  • Disposition to Issuer

    Common Stock

    2011-06-17−4,633→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−17,352→ 0 total
    Exercise: $18.48Exp: 2014-09-30→ Common Stock (17,352 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−2,648→ 0 total
    Exercise: $18.48Exp: 2014-09-30→ Common Stock (2,648 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−11,250→ 3,750 total
    Exercise: $14.36Exp: 2015-03-05→ Common Stock (11,250 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−15,000→ 0 total
    Exercise: $10.82Exp: 2016-02-09→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−27,670→ 0 total
    Exercise: $20.05Exp: 2018-02-10→ Common Stock (27,670 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−14,062→ 938 total
    Exercise: $18.08Exp: 2014-05-13→ Common Stock (14,062 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−938→ 0 total
    Exercise: $18.08Exp: 2014-05-13→ Common Stock (938 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−15,000→ 15,000 total
    Exercise: $10.82Exp: 2016-02-09→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−24,750→ 0 total
    Exercise: $18.46Exp: 2017-02-11→ Common Stock (24,750 underlying)
Footnotes (13)
  • [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $458,289.18 in cash.
  • [F10]This option, which vested with respect to 25% of the shares on March 31, 2010 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 11,332 shares of Endo common stock with an exercise price of $14.33 per share.
  • [F11]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 8,250 shares in the Merger in exchange for a cash payment of $92,205 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F12]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 18,698 shares of Endo common stock with an exercise price of $24.44 per share.
  • [F13]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 20,904 shares of Endo common stock with an exercise price of $26.54 per share.
  • [F2]These restricted shares were assumed by Endo in the Merger in exchange for 3,500 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
  • [F3]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $1,999,851.66 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F4]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $30,498.34 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F5]This option, which vested with respect to 25% of the shares on June 30, 2008 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 14,062 shares in the Merger in exchange for a cash payment of $167,619.04 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F6]This option, which vested with respect to 25% of the shares on June 30, 2008 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 708 shares of Endo common stock with an exercise price of $23.94 per share.
  • [F7]This option, which vested with respect to 25% of the shares on March 31, 2009 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 11,250 shares in the Merger in exchange for a cash payment of $176,006.25 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F8]This option, which vested with respect to 25% of the shares on March 31, 2009 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 2,833 shares of Endo common stock with an exercise price of $19.01 per share.
  • [F9]This option, which vested with respect to 25% of the shares on March 31, 2010 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 15,000 shares in the Merger in exchange for a cash payment of $287,625 representing the difference between the exercise price of the option and the $30.00 per share price.

Documents

1 file

Issuer

AMERICAN MEDICAL SYSTEMS HOLDINGS INC

CIK 0001114200

→
Entity typeother

Related Parties

1
  • filerCIK 0001455934

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 3:26 PM ET
Size
33.7 KB
View on SEC.gov